BP’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-8,918
| Closed | -$4.5M | – | 480 |
|
|
2021
Q2 | $4.5M | Sell |
8,918
-3,926
| -31% | -$1.85M | 0.19% | 107 |
|
|
2021
Q1 | $5.87M | Sell |
12,844
-2,781
| -18% | -$1.33M | 0.21% | 107 |
|
|
2020
Q4 | $7.27M | Sell |
15,625
-14,627
| -48% | -$6.86M | 0.22% | 103 |
|
|
2020
Q3 | $13.3M | Sell |
30,252
-8,348
| -22% | -$3.45M | 0.32% | 85 |
|
|
2020
Q2 | $14M | Sell |
38,600
-2,000
| -5% | -$670K | 0.51% | 40 |
|
|
2020
Q1 | $11.5M | Hold |
40,600
| – | – | 0.49% | 45 |
|
|
2019
Q4 | $13.2M | Buy |
40,600
+300
| +0.7% | +$91K | 0.44% | 50 |
|
|
2019
Q3 | $11.7M | Sell |
40,300
-12,200
| -23% | -$3.49M | 0.43% | 50 |
|
|
2019
Q2 | $15.4M | Hold |
52,500
| – | – | 0.57% | 37 |
|
|
2019
Q1 | $14.4M | Buy |
52,500
+9,500
| +22% | +$2.36M | 0.56% | 42 |
|
|
2018
Q4 | $9.62M | Sell |
43,000
-50,000
| -54% | -$11.7M | 0.4% | 66 |
|
|
2018
Q3 | $22.7M | Hold |
93,000
| – | – | 0.69% | 30 |
|
|
2018
Q2 | $19.3M | Buy |
93,000
+47,000
| +102% | +$9.98M | 0.62% | 34 |
|
|
2018
Q1 | $9.5M | Hold |
46,000
| – | – | 0.34% | 75 |
|
|
2017
Q4 | $8.74M | Sell |
46,000
-15,000
| -25% | -$2.87M | 0.31% | 83 |
|
|
2017
Q3 | $11.5M | Hold |
61,000
| – | – | 0.41% | 62 |
|
|
2017
Q2 | $10.6M | Buy |
61,000
+12,000
| +24% | +$2.02M | 0.39% | 68 |
|
|
2017
Q1 | $7.53M | Buy |
49,000
+9,000
| +23% | +$1.38M | 0.29% | 92 |
|
|
2016
Q4 | $5.64M | Sell |
40,000
-9,000
| -18% | -$1.33M | 0.21% | 132 |
|
|
2016
Q3 | $7.79M | Hold |
49,000
| – | – | 0.3% | 98 |
|
|
2016
Q2 | $7.24M | Hold |
49,000
| – | – | 0.29% | 106 |
|
|
2016
Q1 | $6.93M | Sell |
49,000
-11,000
| -18% | -$1.47M | 0.28% | 113 |
|
|
2015
Q4 | $8.51M | Sell |
60,000
-37,000
| -38% | -$4.93M | 0.35% | 94 |
|
|
2015
Q3 | $11.9M | Buy |
97,000
+40,000
| +70% | +$5.21M | 0.53% | 62 |
|
|
2015
Q2 | $7.39M | Hold |
57,000
| – | – | 0.28% | 119 |
|
|
2015
Q1 | $7.66M | Sell |
57,000
-53,000
| -48% | -$6.83M | 0.24% | 122 |
|
|
2014
Q4 | $13.8M | Hold |
110,000
| – | – | 0.35% | 71 |
|
|
2014
Q3 | $13.4M | Buy |
110,000
+14,000
| +15% | +$1.7M | 0.39% | 56 |
|
|
2014
Q2 | $11.3M | Buy |
96,000
+10,000
| +12% | +$1.18M | 0.36% | 59 |
|
|
2014
Q1 | $10.3M | Buy |
86,000
+49,000
| +132% | +$5.83M | 0.34% | 68 |
|
|
2013
Q4 | $4.12M | Buy |
+37,000
| New | +$3.68M | 0.15% | 150 |
|
Other funds holding TMO
BP's TMO Position: Q3 2021 in Review
BP sold out of Thermo Fisher Scientific (TMO) in Q3 2021, closing a stake of 8,918 shares — an estimated $4.5M sold.
BP first reported a position in TMO in Q4 2013 and held it in 31 quarters. The position peaked at $22.7M in Q3 2018. 2,128 funds tracked by Wall St. Rank hold TMO as of Q3 2021.
- BP reported no remaining Thermo Fisher Scientific position as of Q3 2021 after selling out during the quarter.
- BP sold 8,918 Thermo Fisher Scientific shares in Q3 2021, an estimated $4.5M.
- BP first reported a position in Thermo Fisher Scientific in Q4 2013 and held it in 31 quarters.
- BP's Thermo Fisher Scientific position peaked at $22.7M in Q3 2018.
- 2,128 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.
Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.